This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Making money from home in your spare time is possible. Explore various options that fit into your busy schedule.
24,286 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
A fast-growing mezcal market in Oaxaca is boosting U.S. demand while driving environmental costs. New data show fores...
A niche gold strategy that pairs silver-like cash flow with gold exposure is gaining traction. IAUI offers about 12% ...
A major security misconfiguration at Anthropic left internal assets, including notes on an unreleased model and CEO r...
A famed market forecaster is signaling a bold by-year-end target for the S&P 500, driven by resilient earnings and a ...
A fresh analysis suggests that delaying large withdrawals from an inherited 401(k) until later in retirement—specific...
Anthropic lands London as its Claude tools push into Europe, signaling mainstream adoption of AI-powered coding. The ...
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
VanEck’s Gaming ETF has retooled into a Digital Native Economy ETF, raising doubts about whether its income story can...
As Nvidia signals AI momentum and Marvell rides the wave, investors scan AI bookings and data-center demand to gauge ...
Pi Network hints at significant changes this week as June 28 approaches, raising questions about mainnet progress, po...
Global cybersecurity spending just crossed the $300 billion mark in 2026, as enterprises accelerate AI-enabled securi...